We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

16 hedge funds and large institutions have $1.89M invested in OncoSec Medical Incorporated in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

91% more capital invested

Capital invested by funds: $992K → $1.89M (+$901K)

20% less funds holding

Funds holding: 20 → 16 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$227K
2
DADC
D.A. Davidson & Co
Montana
+$98.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$47K
4
SPC
Sigma Planning Corp
Michigan
+$40.3K
5
BlackRock
BlackRock
New York
+$40K

Top Sellers

Rank Fund Capital Flow
1
CL
CSS LLC
Illinois
-$54K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$37K
3
LPL Financial
LPL Financial
California
-$31K
4
UBS Group
UBS Group
Switzerland
-$10K
5
Victory Capital Management
Victory Capital Management
Texas
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$728K +$227K +5,340 +49%
Vanguard Group
2
Vanguard Group
Pennsylvania
$248K -$9.87K -232 -4%
DADC
3
D.A. Davidson & Co
Montana
$243K +$98.1K +2,306 +75%
6CM
4
683 Capital Management
New York
$164K – – –
BlackRock
5
BlackRock
New York
$109K +$40K +941 +64%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$103K +$14.2K +334 +17%
SPC
7
Sigma Planning Corp
Michigan
$99K +$40.3K +946 +76%
SM
8
Salzhauer Michael
$66K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$50K +$47K +1,105 New
Squarepoint
10
Squarepoint
New York
$38K +$36.3K +853 New
Northern Trust
11
Northern Trust
Illinois
$23K – – –
PAG
12
Private Advisor Group
New Jersey
$22K – – –
CL
13
CSS LLC
Illinois
– -$54K -1,921 Closed
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
– -$37K -1,338 Closed
LPL Financial
15
LPL Financial
California
– -$31K -1,116 Closed
UBS Group
16
UBS Group
Switzerland
– -$10K -364 Closed
Victory Capital Management
17
Victory Capital Management
Texas
– -$10K -327 Closed
Bank of America
18
Bank of America
North Carolina
– +$128 +3 +43%

ONCS Hedge Fund Activity: Q2 2020 in Review

16 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2020, worth a combined $1.89M — up 91% from $992K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ONCS and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $227K. The largest seller was CSS LLC, exiting entirely with an estimated $54K sold.

  • 16 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2020, down from 20 in Q1 2020.
  • Funds reported $1.89M of OncoSec Medical Incorporated stock for Q2 2020, up 91% quarter-over-quarter.
  • 2 funds opened new OncoSec Medical Incorporated positions in Q2 2020 and 6 closed out, a net change of -4 holders.
  • The largest OncoSec Medical Incorporated buyer in Q2 2020 was Renaissance Technologies, an estimated $227K added.
  • The largest OncoSec Medical Incorporated seller in Q2 2020 was CSS LLC, an estimated $54K sold.

Based on aggregated 13F filings for Q2 2020.